echocardiogram

Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trial

By S Mittal et alTaken directly from Heart Rhythm Cardiac device procedures require tissue dissection to free existing device lead(s). The purpose of this study…

View More Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trial
3d heart image

Left atrial appendage occlusion in the UK: prospective registry and data linkage to Hospital Episode Statistics

By I Willits et al This single-arm study has reported the results of the real-world safety and efficacy of LAAO from a multicentre, prospective, observational…

View More Left atrial appendage occlusion in the UK: prospective registry and data linkage to Hospital Episode Statistics

Multimodality imaging of myocardial viability: An expert consensus document from the European Association of Cardiovascular Imaging (EACVI)

By Saadia Aslam This expert consensus document reviews current insight into the underlying pathophysiology and available methods for assessing viability. In particular the document reviews…

View More Multimodality imaging of myocardial viability: An expert consensus document from the European Association of Cardiovascular Imaging (EACVI)
Graphical-demonstration-of-the-reduction-in-waist-circumference

In case you missed it: a summary of the BCS ’21 top 10 trials (Part II)

By Ahmed El-Medany One of the most popular sessions every year, an excellent variety of trials were presented at the 2021 BCS Annual Conference. For…

View More In case you missed it: a summary of the BCS ’21 top 10 trials (Part II)
Figure 1: Taken from Chen et al (2020). Incidence of clinically driven target lesion revascularisation (TLR), target vessel myocardial infarction (TVMI), and target lesion failure (TLF). The table shows the hazard ratio and 95% confidence interval for TLR, TVMI, and TLF in the two-stent vs provisional stent group.

In case you missed it: a summary of the BCS ’21 top 10 trials (Part I)

One of the most popular sessions every year, an excellent variety of trials were presented at the 2021 BCS Annual Conference. For those that were unable to attend, or for the sake of refreshing one’s memory, the following is a summary of all the trials presented…

View More In case you missed it: a summary of the BCS ’21 top 10 trials (Part I)
Echocardiogram Hypertension

Novel pacing system improves clinical response in heart failure patients un-responsive to, or unsuitable for, cardiac resynchronisation therapy

overall, the results looked great. Hopefully, over the course of the next 12 months, we will finish recruitment for the final phase of the study to further confirm the primary safety and efficacy endpoints that we saw with the….

View More Novel pacing system improves clinical response in heart failure patients un-responsive to, or unsuitable for, cardiac resynchronisation therapy
Aerobic Class

Exercise training effective in reducing ambulatory blood pressure in resistant hypertension, results from the EnRicH trial

‘These findings provide clinicians with evidence to embrace moderate-intensity aerobic exercise as a standard coadjutant therapy targeting this patient population.’ The authors state.

View More Exercise training effective in reducing ambulatory blood pressure in resistant hypertension, results from the EnRicH trial
BMJ Visual Summary

FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway

By Elisabeth Mahase Taken Directly from the BMJ doi: https://doi.org/10.1136/bmj.n1898 Criticisms of the US Food and Drug Administration’s accelerated approval process have resurfaced after the recent…

View More FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway